Variant report

Variant	esv3407141
Chromosome Location	chr3:48692473-48695321
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr3:48671879..48673850-chr3:48694137..48695935,2	MCF-7	breast:
2	chr3:48631571..48635730-chr3:48691196..48694379,3	K562	blood:
3	chr3:48682961..48685623-chr3:48693830..48696752,2	MCF-7	breast:
4	chr3:48689444..48692588-chr3:48693029..48695522,3	MCF-7	breast:
5	chr3:48616186..48618444-chr3:48693740..48696673,2	MCF-7	breast:
6	chr3:48689444..48692588-chr3:48693029..48695522,3	MCF-7	breast:

Variant related genes	Relation type
ENSG00000114270	chromatin interactions
ENSG00000211535	chromatin interactions
ENSG00000225697	chromatin interactions

Extended variants
information (count: 113 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:113 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs202245466	chr3:48692502-48692503	Weak transcription Strong transcription Enhancers Bivalent/Poised TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs112461559	chr3:48692512-48692513	Weak transcription Strong transcription Enhancers Bivalent/Poised TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs200636661	chr3:48692525-48692526	Weak transcription Strong transcription Enhancers Bivalent/Poised TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs201369205	chr3:48692539-48692540	Weak transcription Strong transcription Enhancers Bivalent/Poised TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs146177587	chr3:48692550-48692551	Weak transcription Strong transcription Enhancers Bivalent/Poised TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs372958176	chr3:48692554-48692555	Weak transcription Strong transcription Enhancers Bivalent/Poised TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs143958970	chr3:48692595-48692596	Weak transcription Strong transcription Enhancers Bivalent/Poised TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs375968214	chr3:48692602-48692603	Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs370166298	chr3:48692612-48692613	Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs373621912	chr3:48692630-48692631	Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs368695601	chr3:48692666-48692667	Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs182089639	chr3:48692699-48692700	Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs371008111	chr3:48692708-48692709	Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs375450962	chr3:48692762-48692763	Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs368456582	chr3:48692778-48692779	Bivalent Enhancer Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs372403376	chr3:48692800-48692801	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs201146327	chr3:48692805-48692806	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs535832808	chr3:48692832-48692833	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs373101787	chr3:48692833-48692834	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs148277496	chr3:48692840-48692841	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs545718762	chr3:48692864-48692865	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs564314138	chr3:48692885-48692886	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs374148807	chr3:48692936-48692937	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs573006186	chr3:48692946-48692947	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs540554264	chr3:48692947-48692948	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs559749086	chr3:48692972-48692973	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs530145231	chr3:48693033-48693034	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs141322792	chr3:48693034-48693035	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs563673724	chr3:48693076-48693077	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs531045821	chr3:48693081-48693082	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs34608191	chr3:48693103-48693104	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs552449886	chr3:48693109-48693110	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs150792981	chr3:48693110-48693111	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs534953847	chr3:48693112-48693113	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs9848493	chr3:48693121-48693122	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs567693105	chr3:48693146-48693147	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs200430426	chr3:48693170-48693171	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS Genic enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs557008146	chr3:48693212-48693213	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Strong transcription Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs371672025	chr3:48693270-48693271	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Strong transcription Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs139167095	chr3:48693293-48693294	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Strong transcription Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs370247053	chr3:48693300-48693301	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Strong transcription Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs113186423	chr3:48693348-48693349	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Strong transcription Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs557639429	chr3:48693438-48693439	Bivalent/Poised TSS Active TSS Enhancers Strong transcription Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs573090391	chr3:48693441-48693442	Bivalent/Poised TSS Active TSS Enhancers Strong transcription Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs112914180	chr3:48693486-48693487	Bivalent/Poised TSS Active TSS Enhancers Strong transcription Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs576928227	chr3:48693488-48693489	Bivalent/Poised TSS Active TSS Enhancers Strong transcription Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs555746593	chr3:48693489-48693490	Bivalent/Poised TSS Active TSS Enhancers Strong transcription Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs112641953	chr3:48693532-48693533	Bivalent/Poised TSS Active TSS Enhancers Strong transcription Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs186605308	chr3:48693559-48693560	Bivalent/Poised TSS Active TSS Enhancers Strong transcription Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs542205780	chr3:48693624-48693625	Bivalent/Poised TSS Active TSS Flanking Active TSS Strong transcription Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
Glioblastoma multiforme	21080181	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17133270	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Melanoma	20688739	CNVD
Acute myeloid leukemia	21251322	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Kartagener syndrome	16639409	CNVD
Biliary cancer	19435499	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	16397240	CNVD
Breast cancer	22032731	CNVD
Non-small cell lung cancer	20864512	CNVD
Colorectal cancer	16912164	CNVD
Non-small cell lung cancer	19010865	CNVD
Colorectal cancer	16272173	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Acute myeloid leukemia	17268525	CNVD
Salivary gland tumor	18059337	CNVD
Gastric cancer	16891809	CNVD
Night blindness	17160897	CNVD
Cancer	17160897	CNVD
Breast cancer	20409316	CNVD
Lung cancer	17297452	CNVD
Multiple myeloma	16616336	CNVD
Effusion lymphoma	18079361	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Neuroblastoma	20406844	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Urothelial cell carcinoma	18451213	CNVD
Neuroblastoma	17327916	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Melanoma	17363583	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medullary thyroid carcinoma	18765511	CNVD
abnormal development	18461090	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Developmental delay	21147756	CNVD
Urothelial carcinoma	21177765	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:532 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:48673600-48693400	Weak transcription	Placenta Amnion	Placenta Amnion
2	chr3:48673800-48692800	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
3	chr3:48674000-48692600	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
4	chr3:48674000-48693400	Weak transcription	Fetal Brain Male	brain
5	chr3:48674000-48693600	Weak transcription	Brain Substantia Nigra	brain
6	chr3:48674200-48692600	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
7	chr3:48674400-48692800	Weak transcription	Placenta	Placenta
8	chr3:48674400-48692800	Weak transcription	Right Ventricle	heart
9	chr3:48674400-48693600	Weak transcription	Gastric	stomach
10	chr3:48674800-48692600	Strong transcription	Fetal Brain Female	brain
11	chr3:48674800-48695600	Weak transcription	Hela-S3	cervix
12	chr3:48675000-48693600	Weak transcription	A549	lung
13	chr3:48675000-48694200	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
14	chr3:48675000-48697200	Strong transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
15	chr3:48680000-48695400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
16	chr3:48684400-48692600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
17	chr3:48687400-48692600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
18	chr3:48688200-48692600	Weak transcription	Primary T cells from cord blood	blood
19	chr3:48688600-48692600	Strong transcription	Brain Inferior Temporal Lobe	brain
20	chr3:48688600-48692800	Weak transcription	Colonic Mucosa	Colon
21	chr3:48688800-48692800	Weak transcription	Brain Cingulate Gyrus	brain
22	chr3:48689400-48693000	Weak transcription	Rectal Mucosa Donor 31	rectum
23	chr3:48689600-48692600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
24	chr3:48689600-48692800	Weak transcription	Stomach Mucosa	stomach
25	chr3:48690000-48692800	Strong transcription	Cortex derived primary cultured neurospheres	brain
26	chr3:48690200-48692600	Weak transcription	Fetal Intestine Small	intestine
27	chr3:48690200-48693200	Strong transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
28	chr3:48690600-48692600	Strong transcription	H9 Cell Line	embryonic stem cell
29	chr3:48690600-48693600	Weak transcription	HepG2	liver
30	chr3:48691000-48693000	Enhancers	Spleen	Spleen
31	chr3:48691200-48692800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
32	chr3:48691200-48692800	Weak transcription	Thymus	Thymus
33	chr3:48691400-48692600	Strong transcription	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr3:48691400-48693000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
35	chr3:48691400-48693000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
36	chr3:48691400-48693000	Weak transcription	Brain Anterior Caudate	brain
37	chr3:48691600-48692800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
38	chr3:48691600-48693400	Weak transcription	Pancreatic Islets	Pancreatic Islet
39	chr3:48691800-48692600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
40	chr3:48691800-48692800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr3:48691800-48692800	Weak transcription	HUES48 Cell Line	embryonic stem cell
42	chr3:48691800-48693000	Weak transcription	Brain Angular Gyrus	brain
43	chr3:48691800-48693000	Weak transcription	Brain Hippocampus Middle	brain
44	chr3:48692000-48692800	Weak transcription	HUES6 Cell Line	embryonic stem cell
45	chr3:48692000-48693000	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
46	chr3:48692200-48692800	Weak transcription	HUES64 Cell Line	embryonic stem cell
47	chr3:48692200-48693000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
48	chr3:48692200-48693200	Genic enhancers	Brain Germinal Matrix	brain
49	chr3:48692400-48692600	Weak transcription	H1 Cell Line	embryonic stem cell
50	chr3:48692400-48692600	Enhancers	Primary T helper cells PMA-I stimulated	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links